Ending preventable maternal mortality: phase II of a multi-step process to develop a monitoring framework, 2016-2030.
R Rima JolivetAllisyn C MoranMeaghan O'ConnorDoris ChouNeelam BhardwajHolly NewbyJennifer RequejoMarta SchaafLale SayAna LangerPublished in: BMC pregnancy and childbirth (2018)
The indicators identified in Phase II will be used along with the Phase I indicators to monitor progress towards ending preventable maternal deaths. Together, they provide a means for monitoring not only the essential clinical interventions needed to save lives but also the equally important political, social, economic and health system determinants of maternal health and survival. These distal factors are essential to creating the enabling environment and high-performing health systems needed to ensure high-quality clinical care at the point of service for every woman, her fetus and newborn. They complement and support other monitoring efforts, in particular the "Survive, Thrive, and Transform" agenda laid out by the Global Strategy for Women's, Children's and Adolescents' Health (2016-2030) and the SDG3 global target on maternal mortality.
Keyphrases
- phase ii
- healthcare
- pregnancy outcomes
- clinical trial
- mental health
- birth weight
- open label
- young adults
- public health
- physical activity
- double blind
- phase iii
- quality improvement
- palliative care
- risk factors
- type diabetes
- metabolic syndrome
- polycystic ovary syndrome
- randomized controlled trial
- weight gain
- gestational age
- case report
- pain management
- emergency department
- cardiovascular disease
- insulin resistance
- weight loss